MARKET

PYPD

PYPD

Polypid Ltd.
NASDAQ
4.400
+0.210
+5.01%
After Hours: 4.600 +0.2 +4.55% 17:33 03/16 EDT
OPEN
4.200
PREV CLOSE
4.190
HIGH
4.400
LOW
4.110
VOLUME
55.10K
TURNOVER
--
52 WEEK HIGH
5.12
52 WEEK LOW
2.300
MARKET CAP
83.97M
P/E (TTM)
-2.1057
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PYPD last week (0309-0313)?
Weekly Report · 11h ago
Weekly Report: what happened at PYPD last week (0302-0306)?
Weekly Report · 03/09 09:57
Weekly Report: what happened at PYPD last week (0223-0227)?
Weekly Report · 03/02 09:56
PolyPid FY 2025 marketing and business development expense rises to USD 2.0 million (+109.2%)
Reuters · 02/25 21:04
PolyPid Senior Management to Join Citizens 2026 Life Sciences Conference and 38th Annual ROTH Conference Fireside Chats
Reuters · 02/25 13:35
Weekly Report: what happened at PYPD last week (0216-0220)?
Weekly Report · 02/23 09:57
Weekly Report: what happened at PYPD last week (0209-0213)?
Weekly Report · 02/16 09:56
Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Dexcom (DXCM)
TipRanks · 02/13 14:31
More
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Webull offers Polypid Ltd stock information, including NASDAQ: PYPD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PYPD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PYPD stock methods without spending real money on the virtual paper trading platform.